Trial intelligence / Profile preview

Modafinil for consciousness improvement in ICU patients with brain injury

IRCT20141209020258N190Phase 3Completed

Sponsor
Arak University of Medical Sciences
Start
Oct 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in traumatic brain injury (TBI), disorder of consciousness (DOC) and delirium comparing Modafinil with Placebo (2 arms). Primary endpoints: Time required until ventilator isolation, Glasgow Coma Scale score and 3 more. Started Oct 2023; status: completed.

02

Drugs

modafinil
03

Conditions

traumatic brain injury (TBI)disorder of consciousness (DOC)delirium

Beyond the preview

Go deeper on IRCT20141209020258N190.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20141209020258N190.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call